Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
Abigail Klein Leichman

NRx Pharmaceuticals Targets Suicidal Bipolar Depression With Multidrug Therapy

Edmontonians participating in the sixth annual Bridge Of Life Suicide Awareness/Prevention candlelight vigil organized by YEG Mental Health, a group dedicated to raising awareness about mental health issues in the greater Edmonton area. On Friday, September 10, 2021, in Edmonton, Alberta, Canada. (ARTUR WIDAK/NURPHOTO VIA GETTY IMAGES)

Every second of every day, someone in the world attempts suicide.

NRx Pharmaceuticals is developing a drug for people whose suicidal thoughts stem from bipolar depression, the low mood phase associated with the severe mood swings of bipolar disorder.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.